Health Care
TMO · Thermo Fisher Scientific
$675.00 Close · 2026-09-25
Close50-day avg200-day avg
Short-term view (1–4 weeks)
Strong BuyRank #8 of 8580
+ Strengths
- + trading above a rising 50-day trend
- + strong 1-month price momentum
− Risks
- No standout weaknesses
Entry, stop and target levels plus the full factor breakdown are free with an account.Join free
Long-term view (6–24 months)
HoldRank #33 of 8556
+ Strengths
- + above its long-term 200-day trend
- + excellent return per unit of risk
- + persistent 12-month uptrend
− Risks
- − deep drawdown over the past year
- − expensive valuation vs peers
- − low return on equity
Entry, stop and target levels plus the full factor breakdown are free with an account.Join free
Fundamentals
- Market cap
- $249.6B
- P/E (TTM)
- 35.8
- Return on equity
- 13.3%
- Revenue growth (YoY)
- +7.2%
- Net margin
- 15.0%
- Debt / equity
- 0.81
- Dividend yield
- 0.27%
- Beta
- 0.87
- 52-week high
- $682.98
- 52-week low
- $435.27
Latest news
Company news is included with a free account.
Model output for education and research — not financial advice or a personal recommendation. Always do your own research and manage your risk.